Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate

被引:20
作者
Azzali, Giacomo [1 ]
机构
[1] Univ Parma, Sch Med, Dept Human Anat Pharmacol & Forens Med, Lymphatol Lab,Sect Human Anat, I-43100 Parma, Italy
关键词
D O I
10.2353/ajpath.2007.060447
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The distribution and fine structure of the tumor-associated absorbing lymphatic vessel in the tumor mass of prostate adenocarcinoma and of seminal vesicle metastasis in transgenic mice was studied for the purpose of understanding the modality of tumor cell transendothelial passage from the extravasal matrix into the lymphatic vessel. in the tumor mass, two main cell populations were identified: stromal tumor cells and the invasive phenotype tumor (IPT) cells, having characteristics such as a highly electron-dense matrix rich in small granules lacking a dense core and massed nuclear chromatin, which is positive to immunostaining with anti-SV40 large T antigen antibody. Based on the ultrastructural pictures of different moments of the IPT cell transendothelial passage by ultrathin serial sections of the tumor-associated absorbing lymphatic vessel, the manner of its transendothelial passage through the intraendothelial channel, without involving intercellular contacts, was demonstrated. The presence of IPT cells in the parenchyma of satellite lymph node highlights its significant role in metastatic diffusion. The intraendothelial channel is the reply to the lack of knowledge regarding the intravasation of the tumor cell into the lymphatic circulation. The lymphatic endothelium would organize this channel on the basis of tumor cell-endothelial cell-extravasal matrix molecular interactions, which are as yet unidentified.
引用
收藏
页码:334 / 346
页数:13
相关论文
共 83 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   Focus on lymphangiogenesis in tumor metastasis [J].
Achen, MG ;
McColl, BK ;
Stacker, SA .
CANCER CELL, 2005, 7 (02) :121-127
[3]  
Adair T.H., 1985, EXPT BIOL LYMPHATIC, P13
[4]   Transendothelial transport and migration in vessels of the apparatus lymphaticus periphericus absorbens (ALPA) [J].
Azzali, G .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 230, 2003, 230 :41-+
[5]   The lymphatic vessels and the so-called "lymphatic stomata" of the diaphragm: A morphologic ultrastructural and three-dimensional study [J].
Azzali, G .
MICROVASCULAR RESEARCH, 1999, 57 (01) :30-43
[6]  
AZZALI G, 1989, ACTA BIOMED ATENEO P, V61, P41
[7]   On the transendothelial passage of tumor cell from extravasal matrix into the lumen of absorbing lymphatic vessel [J].
Azzali, Giacomo .
MICROVASCULAR RESEARCH, 2006, 72 (1-2) :74-85
[8]  
Balch C M, 2001, Ann Surg Oncol, V8, p1S
[9]  
BEVACQUA SJ, 1990, LYMPHOLOGY, V23, P4
[10]   Axis of evil: molecular mechanisms of cancer metastasis [J].
Bogenrieder, T ;
Herlyn, M .
ONCOGENE, 2003, 22 (42) :6524-6536